Wednesday, December 2, 2009

BioElectronics Announces Worldwide DRTV Strategy

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the details of its worldwide Direct Response Television (DRTV) strategy to further enhance its international marketing efforts for its award-winning, pain relieving ActiPatch and Allay brands. The Company will launch campaigns in Latin America beginning in December, Canada in January, Europe and Australia in the first quarter and is currently in process of negotiating a partnership to enter the lucrative Japanese market.

BioElectronics plans to launch its first international DRTV campaign in Latin America during mid-December and has selected one of the largest full-service direct response companies specializing in the Hispanic market. "We are very excited to be launching our first television advertising within the Latin American market in conjunction with RC Television Production, Inc. (, which is one of the leading DRTV firms in Latin America," commented Andrew Whelan, CEO of BioElectronics. "Over the past few years the size of the international Hispanic DRTV market has grown considerably and we believe our ActiPatch and Allay brands will be very well received. Over the next few weeks millions of consumers within Latin America will begin seeing our advertising on some of the region's largest television networks. Our initial media purchases have been completed and our call center and fulfillment functions have now been set up. While our first Hispanic-oriented campaigns will mainly target the larger companies in South America, we are also excited about the U.S. domestic Hispanic market, which at 45.5 million strong, is the single largest and fastest growing minority group in the United States."

Read full

No comments:

Popular Posts

New York Time

Copyright 2017 ©
Netvision SA and PlanetM
New York, New York, USA 10008
You can copy this content without permission but you must notify us via email.
Otherwise, it is illegal. All rights reserved worldwide
Updated by Carlos Vassallo

Pageviews last month